Who Are we?

We are dedicated to bringing the latest advancements in biomedical technology to Southern Africa. With the vision of ensuring widespread access to advanced healthcare across Africa, we founded Biomedhelix (Pty) Ltd in 2017.

The emergence of mRNA vaccines has marked a groundbreaking moment in medical and scientific history, transforming the field of biotechnology. The COVID-19 pandemic has further highlighted the immense potential of mRNA technology.

At Biomedhelix, we are committed to supporting this new era through our expertise, services, and products. We specialize in designing, developing, and delivering cutting-edge biotechnology and laboratory solutions. Our focus is on establishing state-of-the-art infrastructure for research, development, and GMP manufacturing in the pharmaceutical and healthcare sectors.

True to our name, Biomedhelix (Pty) Ltd, a South African company, actively collaborates with key stakeholders in the medical and biomedical fields. We work closely with partners to implement innovative ideas and develop practical solutions tailored to Southern Africa.

Biobanking is one of our core areas of expertise within the vast field of biotechnology. We provide design and development services for biobanks, guiding our clients in selecting optimal products that suit their specific needs. As a representative of Cryotherm, the leading global manufacturer of cryogenic devices based in Germany, we ensure access to world-class solutions in Southern Africa.

Since 2017, Biomedhelix has been actively involved in working with key stakeholders in Southern Africa on projects related to the distribution of COVID-19 vaccines and the initiation of mRNA pharmaceutical manufacturing.